SEC Form D · filed November 22, 2017
MIRAGEN THERAPEUTICS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Jeffrey S. Hatfield · Boulder, CODirectorWilliam S. Marshall · Boulder, COExec · DirectorJason A. Leverone · Boulder, COExecKevin E. Koch · Boulder, CODirectorBruce L. Booth · Boulder, CODirectorChristopher D. Bowden · Boulder, CODirectorThomas E. Hughes · Boulder, CODirectorPaul D. Rubin · Boulder, COExecAdam S. Levy · Boulder, COExecSylvester W. Jonas · Seattle, WAExecPaul Lidsky · New York, NYDirectorQuentin W. Kahrau · Seattle, WADirectorMark Carhart · New York, NYDirectorAnish J. Parvatanini · CHICAGO, ILDirectorChun E. Liu · PORTLAND, ORDirectorAnthony B. Lennen · Indianapolis, INExecWalter Cook · New York, NYExecJoseph L. Tuner · Boulder, CODirectorArjuna J. Ariathurai · CHICAGO, ILDirectorGlen A. Brunk · Indianapolis, INDirectorAmy D. Glover · Indianapolis, INExec · DirectorPhilip B. Palmer · SAVANNAH, GAExec · DirectorPaul G. Smith · Omaha, NEDirectorHoward D. Ellis · Overland Park, KSExecNull Assure Fund Management Ii · Salt Lake City, UTDirectorQuinn Morgan · New York, NYExecAaron Greenwald · New York, NYDirectorJoseph L. Tuner · Boulder, CODirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗